• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统评价和荟萃分析成人心脏手术死亡率风险预测模型。

Systematic review and meta-analysis of mortality risk prediction models in adult cardiac surgery.

机构信息

Bristol Heart Institute, Translational Health Sciences, University of Bristol, Bristol, UK.

Weill Cornell Medical College, Cornell University, New York, USA.

出版信息

Interact Cardiovasc Thorac Surg. 2021 Oct 29;33(5):673-686. doi: 10.1093/icvts/ivab151.

DOI:10.1093/icvts/ivab151
PMID:34041539
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8557799/
Abstract

OBJECTIVES

The most used mortality risk prediction models in cardiac surgery are the European System for Cardiac Operative Risk Evaluation (ES) and Society of Thoracic Surgeons (STS) score. There is no agreement on which score should be considered more accurate nor which score should be utilized in each population subgroup. We sought to provide a thorough quantitative assessment of these 2 models.

METHODS

We performed a systematic literature review and captured information on discrimination, as quantified by the area under the receiver operator curve (AUC), and calibration, as quantified by the ratio of observed-to-expected mortality (O:E). We performed random effects meta-analysis of the performance of the individual models as well as pairwise comparisons and subgroup analysis by procedure type, time and continent.

RESULTS

The ES2 {AUC 0.783 [95% confidence interval (CI) 0.765-0.800]; O:E 1.102 (95% CI 0.943-1.289)} and STS [AUC 0.757 (95% CI 0.727-0.785); O:E 1.111 (95% CI 0.853-1.447)] showed good overall discrimination and calibration. There was no significant difference in the discrimination of the 2 models (difference in AUC -0.016; 95% CI -0.034 to -0.002; P = 0.09). However, the calibration of ES2 showed significant geographical variations (P < 0.001) and a trend towards miscalibration with time (P=0.057). This was not seen with STS.

CONCLUSIONS

ES2 and STS are reliable predictors of short-term mortality following adult cardiac surgery in the populations from which they were derived. STS may have broader applications when comparing outcomes across continents as compared to ES2.

REGISTRATION

Prospero (https://www.crd.york.ac.uk/PROSPERO/) CRD42020220983.

摘要

目的

心脏外科最常用的死亡率风险预测模型是欧洲心脏手术风险评估系统(ES)和胸外科医生协会(STS)评分。对于哪种评分更准确,以及哪种评分应适用于每个亚组人群,尚无共识。我们旨在对这两种模型进行全面的定量评估。

方法

我们进行了系统的文献回顾,并收集了关于区分度的信息,其量化指标为接受者操作特征曲线下的面积(AUC),以及校准度,其量化指标为实际死亡率与预期死亡率之比(O:E)。我们对个体模型的性能进行了随机效应荟萃分析,并进行了两两比较和按手术类型、时间和大陆的亚组分析。

结果

ES2(AUC 0.783 [95%置信区间(CI)0.765-0.800];O:E 1.102(95% CI 0.943-1.289))和 STS(AUC 0.757 [95% CI 0.727-0.785];O:E 1.111 [95% CI 0.853-1.447])的总体区分度和校准度均较好。两种模型的区分度没有显著差异(AUC 差值为 0.016;95% CI -0.034 至 -0.002;P = 0.09)。然而,ES2 的校准度存在显著的地域差异(P < 0.001),且随着时间推移呈现出校准不足的趋势(P=0.057)。STS 则没有出现这种情况。

结论

ES2 和 STS 是从其衍生的人群中预测成人心脏手术后短期死亡率的可靠预测指标。STS 可能比 ES2 更适用于比较不同大陆的结果。

登记号

PROSPERO(https://www.crd.york.ac.uk/PROSPERO/)CRD42020220983。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca4d/8557799/1a1643c27661/ivab151f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca4d/8557799/c0555aaf327a/ivab151f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca4d/8557799/a166bc573939/ivab151f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca4d/8557799/14f1c90be2e2/ivab151f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca4d/8557799/9a9b01804af0/ivab151f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca4d/8557799/1a1643c27661/ivab151f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca4d/8557799/c0555aaf327a/ivab151f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca4d/8557799/a166bc573939/ivab151f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca4d/8557799/14f1c90be2e2/ivab151f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca4d/8557799/9a9b01804af0/ivab151f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca4d/8557799/1a1643c27661/ivab151f4.jpg

相似文献

1
Systematic review and meta-analysis of mortality risk prediction models in adult cardiac surgery.系统评价和荟萃分析成人心脏手术死亡率风险预测模型。
Interact Cardiovasc Thorac Surg. 2021 Oct 29;33(5):673-686. doi: 10.1093/icvts/ivab151.
2
Evidence-Based Determination of Cut-Off Points for Increased Cardiac-Surgery Mortality Risk With EuroSCORE II and STS: The Best-Performing Risk Scoring Models in a Single-Centre Australian Population.基于证据的 EuroSCORE II 和 STS 增加心脏手术死亡率风险截断点的确定:单一中心澳大利亚人群中表现最佳的风险评分模型。
Heart Lung Circ. 2022 Apr;31(4):590-601. doi: 10.1016/j.hlc.2021.08.026. Epub 2021 Oct 28.
3
Society of Thoracic Surgeons Risk Score and EuroSCORE-2 Appropriately Assess 30-Day Postoperative Mortality in the STICH Trial and a Contemporary Cohort of Patients With Left Ventricular Dysfunction Undergoing Surgical Revascularization.胸外科医师学会风险评分和 EuroSCORE-2 适当地评估了 STICH 试验和接受手术血运重建的左心室功能障碍患者当代队列中的 30 天术后死亡率。
Circ Heart Fail. 2018 Nov;11(11):e005531. doi: 10.1161/CIRCHEARTFAILURE.118.005531.
4
Comparison of EuroSCORE II, Original EuroSCORE, and The Society of Thoracic Surgeons Risk Score in Cardiac Surgery Patients.心脏手术患者中欧洲心脏手术风险评估系统II(EuroSCORE II)、原始欧洲心脏手术风险评估系统(Original EuroSCORE)与胸外科医师协会风险评分的比较
Ann Thorac Surg. 2016 Aug;102(2):573-9. doi: 10.1016/j.athoracsur.2016.01.105. Epub 2016 Apr 23.
5
Comparison of the EuroSCORE II and Society of Thoracic Surgeons 2008 risk tools.EuroSCORE II 与胸外科医师学会 2008 风险工具的比较。
Eur J Cardiothorac Surg. 2013 Dec;44(6):999-1005; discussion 1005. doi: 10.1093/ejcts/ezt122. Epub 2013 Mar 4.
6
Meta-Analysis Comparing Established Risk Prediction Models (EuroSCORE II, STS Score, and ACEF Score) for Perioperative Mortality During Cardiac Surgery.比较心脏手术围手术期死亡率的既定风险预测模型(欧洲心脏手术风险评估系统II、胸外科医师协会评分和欧洲心胸外科协会心力衰竭评分)的Meta分析。
Am J Cardiol. 2016 Nov 15;118(10):1574-1582. doi: 10.1016/j.amjcard.2016.08.024. Epub 2016 Aug 23.
7
The application of European system for cardiac operative risk evaluation II (EuroSCORE II) and Society of Thoracic Surgeons (STS) risk-score for risk stratification in Indian patients undergoing cardiac surgery.欧洲心脏手术风险评估系统II(EuroSCORE II)和胸外科医师协会(STS)风险评分在印度心脏手术患者风险分层中的应用。
Ann Card Anaesth. 2013 Jul-Sep;16(3):163-6. doi: 10.4103/0971-9784.114234.
8
Prediction of operative mortality for patients undergoing cardiac surgical procedures without established risk scores.预测未建立风险评分的心脏手术患者的手术死亡率。
J Thorac Cardiovasc Surg. 2023 Apr;165(4):1449-1459.e15. doi: 10.1016/j.jtcvs.2021.09.010. Epub 2021 Sep 14.
9
Performance of the AusSCORE II and STS Score for Coronary Artery Bypass Grafting in a New Zealand Population.新西兰人群中冠状动脉旁路移植术的AusSCORE II和STS评分表现
Heart Lung Circ. 2021 Apr;30(4):600-604. doi: 10.1016/j.hlc.2020.08.021. Epub 2020 Oct 6.
10
The Performance of the Current Risk Prediction Scoring Systems in Patients Undergoing Anaortic Off-pump Coronary Artery Bypass Grafting.现行风险预测评分系统在非体外循环主动脉瓣下冠状动脉旁路移植术中的应用。
J Korean Med Sci. 2021 Jun 7;36(22):e163. doi: 10.3346/jkms.2021.36.e163.

引用本文的文献

1
Application of the comprehensive complication index and Clavien-Dindo complication classification in cardiac surgery: a retrospective study.综合并发症指数和Clavien-Dindo并发症分类在心脏手术中的应用:一项回顾性研究。
BMC Cardiovasc Disord. 2025 Apr 18;25(1):299. doi: 10.1186/s12872-025-04754-0.
2
Performance of the EuroSCORE in coronary artery bypass graft in Colombia, a middle-income country: A retrospective cohort.欧洲心脏手术风险评估系统(EuroSCORE)在中等收入国家哥伦比亚冠状动脉搭桥术中的表现:一项回顾性队列研究。
World J Cardiol. 2025 Mar 26;17(3):100506. doi: 10.4330/wjc.v17.i3.100506.
3
Effect of early administration of tetracosactide on mortality and host response in critically ill patients requiring rescue surgery: a sensitivity analysis of the STOPSHOCK phase 3 randomized controlled trial.

本文引用的文献

1
Validation and quality measurements for STS, EuroSCORE II and a regional risk model in Brazilian patients.巴西患者的 STS、EuroSCORE II 和区域性风险模型的验证和质量测量。
PLoS One. 2020 Sep 10;15(9):e0238737. doi: 10.1371/journal.pone.0238737. eCollection 2020.
2
The American Society of Thoracic Surgery Score versus EuroSCORE I and EuroSCORE II in Israeli Patients Undergoing Cardiac Surgery.美国胸外科医师协会评分与欧洲心脏手术风险评估系统I及欧洲心脏手术风险评估系统II在接受心脏手术的以色列患者中的比较
Isr Med Assoc J. 2019 Oct;21(10):671-675.
3
An In-hospital Mortality Risk Model for Patients Undergoing Coronary Artery Bypass Grafting in China.
早期给予促肾上腺皮质激素对需要抢救性手术的危重症患者死亡率和宿主反应的影响:STOPSHOCK 阶段 3 随机对照试验的敏感性分析。
Mil Med Res. 2024 Aug 19;11(1):56. doi: 10.1186/s40779-024-00555-2.
4
Comparison of machine learning techniques in prediction of mortality following cardiac surgery: analysis of over 220 000 patients from a large national database.机器学习技术在心脏手术后死亡率预测中的比较:来自大型国家数据库的 22 万多例患者的分析。
Eur J Cardiothorac Surg. 2023 Jun 1;63(6). doi: 10.1093/ejcts/ezad183.
5
Periprocedural adverse events after revascularisation: the importance of getting off to a good start.血运重建术后的围手术期不良事件:有一个良好开端的重要性。
EuroIntervention. 2023 Mar 20;18(15):1220-1221. doi: 10.4244/EIJ-E-22-00054.
6
The performance of EuroSCORE II in CABG patients in relation to sex, age, and surgical risk: a nationwide study in 14,118 patients.EuroSCORE II 在 CABG 患者中的表现与性别、年龄和手术风险的关系:一项涉及 14118 名患者的全国性研究。
J Cardiothorac Surg. 2023 Jan 19;18(1):40. doi: 10.1186/s13019-023-02141-4.
中国冠状动脉旁路移植术患者住院死亡率风险模型。
Ann Thorac Surg. 2020 Apr;109(4):1234-1242. doi: 10.1016/j.athoracsur.2019.08.020. Epub 2019 Sep 18.
4
[2018 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS)].[2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南。欧洲心脏病学会(ESC)和欧洲心胸外科学会(EACTS)心肌血运重建特别工作组]
G Ital Cardiol (Rome). 2019 Jul-Aug;20(7-8 Suppl 1):1S-61S. doi: 10.1714/3203.31801.
5
Assessment of heterogeneity in an individual participant data meta-analysis of prediction models: An overview and illustration.个体参与者数据荟萃分析中预测模型异质性的评估:概述和实例。
Stat Med. 2019 Sep 30;38(22):4290-4309. doi: 10.1002/sim.8296. Epub 2019 Aug 2.
6
Measures for evaluation of prognostic improvement under multivariate normality for nested and nonnested models.多变量正态性下嵌套和非嵌套模型预后改善评估的措施。
Stat Med. 2019 Sep 10;38(20):3817-3831. doi: 10.1002/sim.8204. Epub 2019 Jun 18.
7
PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration.PROBAST:一种用于评估偏倚风险和预测模型研究适用性的工具:说明和阐述。
Ann Intern Med. 2019 Jan 1;170(1):W1-W33. doi: 10.7326/M18-1377.
8
Assessment of the EuroSCORE II in a New Zealand Tertiary Centre.新西兰一家三级医疗中心的 EuroSCORE II 评估。
Heart Lung Circ. 2019 Nov;28(11):1670-1676. doi: 10.1016/j.hlc.2018.09.004. Epub 2018 Sep 27.
9
Prospective validation of the EuroSCORE II risk model in a single Dutch cardiac surgery centre.欧洲心脏手术风险评估系统II(EuroSCORE II)风险模型在荷兰一家心脏外科中心的前瞻性验证
Neth Heart J. 2018 Nov;26(11):540-551. doi: 10.1007/s12471-018-1161-x.
10
A framework for meta-analysis of prediction model studies with binary and time-to-event outcomes.用于二元和事件发生时间结局的预测模型研究的Meta分析框架。
Stat Methods Med Res. 2019 Sep;28(9):2768-2786. doi: 10.1177/0962280218785504. Epub 2018 Jul 23.